Market Trends of Anti-Snoring Industry
The Mandibular Advancement Devices (MAD) Sub-segment is Expected to Hold a Significant Market Share During the Forecast Period
Mandibular advancement devices (MAD) are pivotal in the anti-snoring device market, owing to their proven effectiveness and non-invasive approach. These devices aim to mitigate snoring and address mild to moderate obstructive sleep apnea by shifting the lower jaw forward during sleep.
Moreover, increasing investments in sleep research, a surge in product approvals and launches, and innovative developments by global key players are propelling the growth of this segment in the market.
Numerous studies underscore the effectiveness of MADs in curbing snoring, forecasting a rise in their adoption. For instance, at SLEEP 2024 in Houston, a recent study introduced a validated technology for tracking mandibular jaw movements. This technology established a clear link between the protrusion levels of MADs and sleep duration. The study also highlighted a 10.6% reduction in snoring symptoms. Given these insights, a heightened demand for anti-snoring solutions is anticipated, signaling robust growth for this segment.
Additionally, key players' product launches are set to bolster segment growth. For instance, Glidewell unveiled the Silent Nite Sleep Appliance, an extension of its Silent Nite brand, in July 2022. This new MAD targets both snoring and obstructive sleep apnea (OSA).
In conclusion, ongoing research and product innovations are poised to fuel the growth of this sub-segment in the coming years.
North America is Expected to Hold a Significant Share in the Market During the Forecast Period
North America is poised to witness a substantial market share, driven by a confluence of factors: a pronounced incidence of sleep disorders, robust spending on research and development (R&D), a flurry of product launches and approvals, and a dense concentration of market players.
Snoring frequently signals the presence of obstructive sleep apnea (OSA), a prevalent sleep disorder. Given the widespread prevalence of sleep disorders, there's a surging demand for anti-snoring devices, fueling market expansion. For instance, data from the Sleep and Sleep Disorders statistics, updated in November 2022, highlighted that about 34% of females and 35.8% of males in the United States experienced short sleep durations in 2022. This pronounced prevalence of sleep apnea, often arising from snoring, is set to escalate the demand for anti-snoring devices, propelling market growth in the region.
Moreover, individuals with excess weight are more prone to snoring, primarily due to additional soft tissue in the mouth and throat. Given the region's obesity challenges, there's a heightened incidence of snoring, suggesting robust market growth in the coming years. For context, the Obesity Atlas 2024 report noted that in 2022, 31.28 million children in the United States had a high body mass index (BMI), with projections reaching 35.25 million by 2035. This rising obesity trend amplifies the risk of snoring, hinting at a surge in anti-snoring device usage and, consequently, market growth.
Additionally, as per the May 2022 update from the National Institute of Health's Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC), United States spending on sleep research R&D was USD 580 million in 2023, with a slight dip to an anticipated USD 575 million in 2024. Such government backing in sleep research not only underscores its importance but also paves the way for market players to innovate and develop advanced devices for snoring management, further fueling market growth.
Moreover, the region's rising product approvals and launches contribute significantly to market growth. For instance, in November 2023, Vivos Therapeutics, Inc. received 510(k) clearance from the United States Food and Drug Administration for the Vivos’ removable CARE (Complete Airway Repositioning and Expansion) oral appliances. This appliance is a non-invasive treatment for snoring and sleep apnea.
In conclusion, the North American market is set for growth, bolstered by the region's challenges with sleep disorders and obesity, escalating R&D investments, and a steady stream of product innovations and approvals.
